Arizona Tribune - Boulevard

NYSE - LSE

RBGPF	-3.31%	68.5	$
CMSC	0.05%	21.3	$
BCC	-0.95%	78.01	$
BCE	0.55%	23.59	$
BTI	-1.01%	55.57	$
NGG	-0.24%	79.16	$
CMSD	-0.09%	21.16	$
GSK	-1.13%	50.25	$
RELX	-0.3%	36.43	$
RYCEF	-2.09%	20.08	$
RIO	-0.78%	102.5	$
JRI	-1.4%	12.18	$
VOD	0%	16.04	$
BP	1.68%	42.87	$
AZN	-0.35%	162.13	$

Featured

India's top court drops criminal cases against protesters

India's Supreme Court called off criminal investigations on Tuesday against most of the protesters who took part in demonstrations over the leak of a medical exam paper that forced the resignation of the education minister.

Philippine couple married in hip-deep floodwaters

A Philippine couple tied the knot on Tuesday at a Catholic church swamped in hip-deep waters, as heavy rains have pummelled large parts of the country for a month.

Last news

DirectTrust(R) Announces Appointment of New and Returning Board Members, Board Officers

Newly elected leaders will advance DirectTrust's efforts to build trust in healthcare data exchange

MIRA Pharmaceuticals Announces New Data Underscoring Potential of SKNY-1 - A Drug Candidate Pending Acquisition - To Disrupt Weight Loss and Smoking Cessation Markets Without CNS Side Effects

MIAMI, FL / ACCESS Newswire / June 25, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company focused on developing novel therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced new in vitro preclinical data generated by Eurofins supporting the therapeutic potential of SKNY-1, a next-generation oral drug candidate being developed by SKNY Pharmaceuticals, Inc. ("SKNY"). MIRA has signed a definitive agreement to acquire SKNY, and the proposed transaction remains subject to regulatory review and shareholder approval.

Mental Health America of Central Carolinas Launches Inaugural Southeast Regional Conference on Mental Health

A Transformative Gathering to Advance Advocacy, Education and Access Across the Southeast Region

Aytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM)

DENVER, CO / ACCESS Newswire / June 25, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced the appointment of Dr. Gerwin Westfield, PhD as Senior Vice President of Scientific Affairs, effective June 30, 2025. In his role, Dr. Westfield will oversee the Company's medical and scientific affairs strategies, with a primary focus on the upcoming commercial launch of EXXUA™ (gepirone) extended-release tablets ("EXXUA"), a novel, branded, United States Food and Drug Administration ("FDA") approved treatment for major depressive disorder ("MDD") in adults in the United States.

Interactive Strength Inc. (Nasdaq:TRNR) Announces 1-for-10 Reverse Split

Reverse Split Becomes Effective Friday, June 27, 2025Shareholder- and Board-Approved Action Reduces Shares Outstanding to 1.4 million from 13.9 million, Expected to Ensure Continued Compliance with Nasdaq Listing Requirements

Wellgistics Health (NASDAQ:WGRX) Accelerates Platform Growth in Q2 With 116 Manufacturer Partnerships, 12,400+ New Products, and 275+ Pharmacies Added to Its Expanding Tech Based Drug Ecosystem

TAMPA, FL / ACCESS Newswire / June 25, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare technology company focused on building the future of prescription access and distribution, today announced significant Q2 2025 operational results-adding 116 new pharmaceutical manufacturer partnerships, over 12,400 new products (NDCs), and 275+ pharmacies to its national platform.

Evotec Joins NURTuRE-AKI Consortium to Gain Multi-Omics-Based Molecular Understanding of Acute Kidney Injury

NURTuRE-AKI is a novel observational study that collects longitudinal data and biological samples from fully consented acute kidney injury ("AKI") patients, developed as part of a research consortium led by Kidney Research UKThe study focuses on 3 clearly defined cohorts: AKI of iatrogenic origin (following cardiac surgery), AKI to chronic kidney disease ("CKD") transition and pediatric AKI.This partnership will enable Evotec to understand human disease progression on a molecular level and to perform targeted drug discovery in the field of AKI.

US judge backs using copyrighted books to train AI

A US federal judge has sided with Anthropic regarding training its artificial intelligence models on copyrighted books without authors' permission, a decision with the potential to set a major legal precedent in AI deployment.

US judge allows using pirated books to train AI

A federal judge has sided with the AI company Anthropic in its practice of training a chatbot on copyrighted books without permission from the authors.

French volunteers hand migrants water beyond the crowded beach

Many others had rushed to the beach to cool off in the heat, but French retiree Sylvie Baudelet and another volunteer were busy handing out water, tea and coffee to thirsty migrants.

France ordered to compensate family of jogger killed by toxic algae

A French court on Tuesday ordered the state to compensate the family of a 50-year-old man who died in 2016 during a run after inhaling poisonous gas emitted by rotting green algae piled along the country's western coast.

France charges Briton over staged Disneyland 'marriage' with child

France charged a British citizen with offences including money-laundering and identity theft after he allegedly organised a bizarre ceremony at Disneyland Paris where he played the role of the groom in a fake marriage with a nine-year-old girl, prosecutors said Tuesday.

Brazil records 62% jump in area burned by forest fires: monitor

Historic forest fires in Brazil last year scorched through an area larger than the size of Italy, recording a burned area some 60 percent higher than average of the last four decades, said a report released Tuesday.

Vietnam puts 41 on trial in $45 mn corruption case

A $45 million corruption trial against 41 people including state officials began in Vietnam on Tuesday, part of the communist state's wide-ranging anti-graft drive.

Trial of Sean Combs approaches final stretch

The high-profile trial of Sean "Diddy" Combs is approaching its final stretch, with both teams poised to rest their cases as soon as Tuesday.

Judge tells Australian mushroom murder jury to put emotion aside

Jury members in the trial of an Australian woman accused of murdering three relatives with a toxic mushroom-laced meal were warned Tuesday to cast aside any "prejudice and sympathy".

Glamour, gripes as celebs head to Venice for exclusive Bezos wedding

Celebrities in superyachts sail into Venice this week for the three-day wedding party of Amazon tycoon Jeff Bezos and Lauren Sanchez, despite irate locals who say the UNESCO city is no billionaire's playground.

Pro-Palestinian protest leader details 104 days spent in US custody

Mahmoud Khalil, one of the most prominent leaders of pro-Palestinian protests on US campuses, recounted his experience surviving 104 days in Immigration and Customs Enforcement detention after being targeted for deportation by the Trump administration.

Envela Added to Membership of US Small-Cap Russell 2000 Index

IRVING, TX / ACCESS Newswire / June 24, 2025 / Envela Corporation was added as a member of the US small-cap Russell 2000® Index, effective after the US market opens on June 30 as part of the 2025 Russell indexes reconstitution. Membership in the Russell 2000® Index, which remains in place for one year, is based on membership in the broad-market Russell 3000® Index. The stock also was automatically added to the appropriate growth and value indexes.

CureVac Announces Voting Results of General Meeting

TÜBINGEN, GERMANY AND BOSTON, MA / ACCESS Newswire / June 24, 2025 / CureVac N.V. (NASDAQ:CVAC), a pioneering multinational biotech company developing a new class of transformative medicines based on messenger RNA (mRNA), today announced the voting results of the Company's Annual General Meeting.

Jaguar Health Announces Extension of the Maturity Date of its Convertible Promissory Notes from Recently Closed Bridge Financing to January 30, 2026

Company's CEO, board members, other C-suite members, and institutional and accredited investors are participants in the extension of the bridge financing

Union Pacific Sued Over Train Sparks that Allegedly Ignited Rowena Fire

Plaintiffs Seek Justice for Destruction of Property, Evacuations, and Environmental Damage in Oregon Wildfire

Dolphin Subsidiaries and Clients Have Successful Showing at Cannes Lions Festival of Creativity 2025

CANNES, FR / ACCESS Newswire / June 24, 2025 / Dolphin (NASDAQ:DLPN), a leading entertainment marketing and content production company, today announced its participation in several activations at last week's 2025 Cannes Lions Festival of Creativity in Cannes, France through its subsidiaries Always Alpha and The Door. Recognized as the 2025 Agency of the Year by Observer, Dolphin's agencies participated in panels and events and represented clients on the Croisette throughout the week of the conference, which focuses on celebrating creative minds in the advertising industry.

SOHM, Inc. Sets Strategic Goals to Enter Biotechnology-Driven Cosmeceuticals Market

CHINO HILLS, CALIFORNIA / ACCESS Newswire / June 24, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, health and wellness solutions, proudly announces that it has established strategic goals to expand into the development of biotechnology-based cosmeceuticals as part of its long-term growth strategy.

CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment Discussing Glioblastoma Multiforme (GBM) and Lead Product Candidate TPI 287

Moderated discussion with founding physician of the Brain Tumor Center and Director of Neuro-Oncology at Piedmont Atlanta Hospital, Dr. Erin Dunbar

viemaa Recognized as One of RangeMe's Top Health & Beauty Brands

Featured in MMR Magazine and Named a Top 100 Cosmetics Trend by TRENDHUNTER™

Aspire Biopharma Holdings, Inc., Announces Last Patient Dosed in Phase 1 Clinical Trial of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

Enrollment Completed on Schedule; Topline Results Expected Mid Q3 2025

LeBron James 2014 NBA Finals Game-Worn Jersey for $1 Million at Infinite Auctions

MESA, ARIZONA / ACCESS Newswire / June 24, 2025 / Infinite Auctions, a premier sports memorabilia auction house and a wholly owned subsidiary of Medical Care Technologies Inc. (OTC PINK:MDCE), is proud to announce the offering of a truly iconic piece of basketball history - a LeBron James game-worn jersey from Game 4 of the 2014 NBA Finals, marking his final home game as a member of the Miami Heat.

Hi Solutions Continues National Expansion with Premier Dallas Acquisition

Acquires Kelltech SystemsExpands its Autonomous Home™ Presence to North Texas

Ensysce Biosciences Accelerates PF614-MPAR-102 Study with Full Enrollment of Part 2

~ Treatment to Evaluate Effect of Food on Overdose Protection of MPAR ~~ Grant Funds from NIDA Accelerating Clinical Development Program ~

Ambience Healthcare's "Patient Recap" Offers Clinicians the First Chart Summarization Technology from an Ambient AI Platform

An industry first: Ambience Healthcare becomes the only ambient AI to deliver comprehensive patient context before encounters, extending beyond documentation to clinical workflow transformation

Ainos and Kenmec Launch Strategic Partnership to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia

AI Nose and SLM SmellTech platform enter scale-up phase targeting robotics, automation, and environmental sensing marketsKenmec and Ainos to show case AI Nose and SLM in Automation Taipei 2025 in August

Arizona Tribune - Boulevard (English)